Prognostic value of admission blood glucose level in patients with and without diabetes mellitus who sustain ST segment elevation myocardial infarction complicated by cardiogenic shock

Critical Care

Volumn 17, Issue 5, 2013, Pages

  Yang, Jeong H ^a   Song, Pil S ^b   Song, Young B ^a   Hahn, Joo Yong ^a   Choi, Seung Hyuk ^a   Choi, Jin Ho ^a   Lee, Sang H ^a   Jeong, Myung Ho ^c   Kim, Young Jo ^d   Gwon, Hyeon Cheol ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c Chonnam National University   (South Korea)

^d Young Nam University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW MOLECULAR WEIGHT HEPARIN; ORAL ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ANTERIOR MYOCARDIAL INFARCTION; ARTICLE; ARTIFICIAL VENTILATION; CARDIOGENIC SHOCK; CLINICAL ASSESSMENT TOOL; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOBAL REGISTRY OF ACUTE CORONARY EVENT SCORE; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; INTRAAORTIC BALLOON PUMP; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTOLIC BLOOD PRESSURE; THROMBOLYSIS IN MYOCARDIAL INFARCTION SCORE; ANALYSIS; BLOOD; CLINICAL TRIAL; COMPLICATION; HEART INFARCTION; MIDDLE AGED; REGISTER; RISK FACTOR; SHOCK, CARDIOGENIC; SOUTH KOREA;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT ADMISSION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; REPUBLIC OF KOREA; RISK FACTORS; SHOCK, CARDIOGENIC;

EID: 84884848048     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13035     Document Type: Article

References (25)

1. Thiele H, Allam B, Chatellier G, Schuler G, Lafont A. Shock in acute myocardial infarction: the Cape Horn for trials?. Eur Heart J 2010, 31:1828-1835. 10.1093/eurheartj/ehq220, 20610640.
2. Valente S, Lazzeri C, Vecchio S, Giglioli C, Margheri M, Bernardo P, Comeglio M, Chiocchini S, Gensini GF. Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock. Int J Cardiol 2007, 114:176-182. 10.1016/j.ijcard.2006.01.024, 16737749.
3. Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, Asano K, Kuroda T, Tanaka K, Masuyama T, Hori M, Fujii K. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 2003, 41:1-7.
4. Goldberg RJ, Kramer DG, Lessard D, Yarzebski J, Gore JM. Serum glucose levels and hospital outcomes in patients with acute myocardial infarction without prior diabetes: a community-wide perspective. Coron Artery Dis 2007, 18:125-131. 10.1097/01.mca.0000236291.79306.98, 17301604.
5. Mladenovic V, Zdravkovic V, Jovic M, Vucic R, Iric-Cupic V, Rosic M. Influence of admission plasma glucose level on short- and long-term prognosis in patients with ST-segment elevation myocardial infarction. Vojnosanit Pregl 2010, 67:291-295. 10.2298/VSP1004291M, 20465157.
6. Hoebers LP, Damman P, Claessen BE, Vis MM, Baan J, van Straalen JP, Fischer J, Koch KT, Tijssen JG, de Winter RJ, Piek JJ, Henriques JP. Predictive value of plasma glucose level on admission for short and long term mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Am J Cardiol 2012, 109:53-59. 10.1016/j.amjcard.2011.07.067, 21944676.
7. Timmer JR, van der Horst IC, Ottervanger JP, Henriques JP, Hoorntje JC, de Boer MJ, Suryapranata H, Zijlstra F. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J 2004, 148:399-404. 10.1016/j.ahj.2004.04.007, 15389225.
8. Marfella R, Siniscalchi M, Esposito K, Sellitto A, De Fanis U, Romano C, Portoghese M, Siciliano S, Nappo F, Sasso FC, Mininni N, Cacciapuoti F, Lucivero G, Giunta R, Verza M, Giugliano D. Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care 2003, 26:3129-3135. 10.2337/diacare.26.11.3129, 14578250.
9. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000, 355:773-778. 10.1016/S0140-6736(99)08415-9, 10711923.
10. Krinsley JS, Egi M, Kiss A, Devendra AN, Schuetz P, Maurer PM, Schultz MJ, van Hooijdonk RT, Kiyoshi M, Mackenzie IM, Annane D, Stow P, Nasraway SA, Holewinski S, Holzinger U, Preiser JC, Vincent JL, Bellomo R. Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study. Crit Care 2013, 17:R37. 10.1186/cc12547, 3733432, 23452622.
11. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hebert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360:1283-1297.
12. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, Giugliano RP, McCabe CH, Braunwald E. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation - an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000, 102:2031-2037. 10.1161/01.CIR.102.17.2031, 11044416.
13. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van De Werf F, Avezum A, Goodman SG, Flather MD, Fox KA. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003, 163:2345-2353. 10.1001/archinte.163.19.2345, 14581255.
14. Global Registry of Acute Coronary Events [http://www.outcomes-umassmed.org/grace].
15. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845. 10.2307/2531595, 3203132.
16. Pencina MJ, D'Agostino RB, D'Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27:157-172. discussion 207-212, 10.1002/sim.2929, 17569110.
17. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002, 359:2140-2144. 10.1016/S0140-6736(02)09089-X, 12090978.
18. Straumann E, Kurz DJ, Muntwyler J, Stettler I, Furrer M, Naegeli B, Frielingsdorf J, Schuiki E, Mury R, Bertel O, Spinas GA. Admission glucose concentrations independently predict early and late mortality in patients with acute myocardial infarction treated by primary or rescue percutaneous coronary intervention. Am Heart J 2005, 150:1000-1006. 10.1016/j.ahj.2005.01.033, 16290985.
19. Thalib L, Zubaid M, Rashed W, Suwaidi JA, Almahmeed W, Alozairi E, Alanbaei M, Sulaiman K, Amin H, Al-Motarreb A. Impact of diabetic status on the hyperglycemia-induced adverse risk of short term outcomes in hospitalized patients with acute coronary syndromes in the Middle East: findings from the Gulf registry of Acute Coronary Events (Gulf RACE). Clin Med Res 2011, 9:32-37. 10.3121/cmr.2010.946, 3064757, 20852085.
20. Ishihara M, Kojima S, Sakamoto T, Kimura K, Kosuge M, Asada Y, Tei C, Miyazaki S, Sonoda M, Tsuchihashi K, Yamagishi M, Shirai M, Hiraoka H, Honda T, Ogata Y, Ogawa H. Comparison of blood glucose values on admission for acute myocardial infarction in patients with versus without diabetes mellitus. Am J Cardiol 2009, 104:769-774. 10.1016/j.amjcard.2009.04.055, 19733709.
21. Sechterberger MK, Bosman RJ, Oudemans-van Straaten HM, Siegelaar SE, Hermanides J, Hoekstra JB, De Vries JH. The effect of diabetes mellitus on the association between measures of glycaemic control and ICU mortality: a retrospective cohort study. Crit Care 2013, 17:R52. 10.1186/cc12572, 3733428, 23510051.
22. Sanjuan R, Nunez J, Blasco ML, Minana G, Martinez-Maicas H, Carbonell N, Palau P, Bodi V, Sanchis J. Prognostic implications of stress hyperglycemia in acute ST elevation myocardial infarction. Prospective observational study. Rev Esp Cardiol 2011, 64:201-207. 10.1016/j.recesp.2010.08.002, 21330037.
23. Kozieradzka A, Kaminski KA, Maciorkowska D, Olszewska M, Dobrzycki S, Nowak K, Kralisz P, Prokopczuk P, Musial WJ. GRACE, TIMI, Zwolle and CADILLAC risk scores - do they predict 5-year outcomes after ST-elevation myocardial infarction treated invasively?. Int J Cardiol 2011, 148:70-75. 10.1016/j.ijcard.2009.10.026, 19923016.
24. Sleeper LA, Reynolds HR, White HD, Webb JG, Dzavik V, Hochman JS. A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry. Am Heart J 2010, 160:443-450. 10.1016/j.ahj.2010.06.024, 20826251.
25. Zhang M, Li J, Cai YM, Ma H, Xiao JM, Liu J, Zhao L, Guo T, Han MH. A risk-predictive score for cardiogenic shock after acute myocardial infarction in Chinese patients. Clin Cardiol 2007, 30:171-176. 10.1002/clc.20063, 17443658.